|Capitol Connections November 9, 2012|
November 9, 2012
IACP Executive Vice President & CEO Releases Statement on Congressman Markey’s Plans for Legislation
Yesterday, IACP distributed a press release to IACP members, members of the media, state Boards of Pharmacy, pharmacy associations and other stakeholders regarding Congressman Edward J. Markey’s (D-Mass.) plans to introduce legislation to strengthen oversight of compounding pharmacies. Click here to view article in its entirety.
IACP to Testify before Senate HELP Hearing on November 15, 2012
IACP’s David G. Miller, RPh, Executive Vice President & CEO, has been invited to testify before a U.S. Senate HELP Committee hearing, “Pharmacy Compounding: Implications of the 2012 Meningitis Outbreak” on November 15, 2012 at 10 am EST, in 106 Dirksen Senate Office Building in Washington, D.C. Click here to view article in its entirety.
Meningitis Outbreak: Media Tools for Members
Last week, a letter from IACP Executive Vice President & CEO David G. Miller, RPh, was sent to IACP members in an effort to assist with outreach to local media in light of the recent meningitis crisis, which included a downloadable Op Ed piece, designed to be customized and submitted to local newspapers. Click here to view the letter.
Have You Ever Received an FDA Warning Letter?
Members of the media are contacting compounding pharmacies which received an FDA warning letter at any time. IACP wants to make certain that messaging about the practice of pharmacy compounding remains both consistent and factual. Click here to view article in its entirety.
Protect your privilege to compound. Contribute to IACP’s Public Affairs Fund today!
IACP’s Public Affairs campaign is not just about getting the word out about compounding. The autistic child that requires an uncommon dosage of a particular medication, the diabetic allergic to an ingredient in a manufactured drug and even the elephant being treated by a local veterinarian are the very essence of this campaign. The Academy also wants to ensure that the option for patients to choose personalized medication solutions remains accessible. Click here to view article in its entirety.
IACP Helps Coordinate Response to K-V Pharmaceutical Filing
IACP wishes to thank Wedgewood Pharmacy for taking the lead in responding to a filing with the International Trade Commission by K-V Pharmaceutical over the compounding of 17-P. IACP is also filing comments with publicly available documents supporting the continued compounding of 17-P.
To date, there is no court order governing the compounding of 17-P. IACP will keep members apprised of any activity which would affect the ability to compound 17-P. Click here to view public interest letter to the U.S. International Trade Commission.
CMS Issues Policy on Billing for Prepared Drugs Under Medicare Part B
In past issues of Capitol Connections IACP has reported on its work over the past year to have the Centers for Medicare and Medicaid Services (CMS) clarify its position on the billing of “prepared drugs”. Click here to view article in its entirety.
In light of the unfortunate events tied to the recent meningitis outbreak, regulations and standards of practice compounders must adhere to are now being placed under the microscope by many. Several state Boards of Pharmacy are reviewing existing regulations and even considering potential new laws that will affect compounders. Several Boards are also "reinterpreting" existing regulations. IACP has developed a running list of states currently examining laws/regulations. Click here to view article in its entirety.
Media Coverage of Compounding & Meningitis Outbreak
Below is a compilation of print, radio and television news pieces on pharmacy compounding and the meningitis outbreak crisis.
Mass. pharmacy board chief fired after meningitis outbreak - The Boston Globe
Framingham pharmacy staff faces work limit - The Boston Globe
Compounding pharmacies fill important medical niche - The Boston Globe
Minutes detail NECC’s history with regulators - The Boston Herald
Click here to view full list.
IACP Welcomes New Corporate Partner
The IACP Corporate Partner program engages corporate leaders in the pharmacy compounding community by connecting them with IACP’s more than 2,700 pharmacists, technicians, students, and members of the compounding community. We encourage all IACP members to support these corporate partners that are instrumental in our joint effort to protect and grow this vital part of quality health care. Thank you for your continued support of pharmacy compounding!
Congratulations to the following IACP Members who have achieved Pharmacy Compounding Accreditation Board (PCAB) Accreditation!
A & O Specialty Pharmacy, David Smith, PharmD, FIACP, Salinas, Calif., (Sterile & Non-Sterile Compounding – Initial Accreditation)
Belvidere Pharmacy, Shara Rudner, RPh, FIACP, Highland Park, NJ., (Sterile & Non-Sterile Compounding – Reaccreditation)
Click here to view IACP’s Upcoming Events.
Stay connected to IACP by joining our online communities!
Tell us how compounded pharmaceuticals have helped you, someone you know, or how you have helped someone as a practicing compounding pharmacist. Help us protect your continued access to pharmacy compounding!
Share the P3 community and the value and necessity of personalized prescriptions with your friends.